Jeffrey B. Locke

Novel Ribosomal Mutations in <i>Staphylococcus aureus</i> Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)

Jeffrey B. Locke, M.T. Hilgers, Karen Joy Shaw · Antimicrobial Agents and Chemotherapy · 2009 · 202 citations · Full text

The IL-8 Protease SpyCEP/ScpC of Group A Streptococcus Promotes Resistance to Neutrophil Killing

Annelies S. Zinkernagel, Anjuli M. Timmer, Morgan A. Pence et al. · Cell Host & Microbe · 2008 · 180 citations · Full text

Inflammation, Medical Microbiology, Virulence Factor +10

Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant <i>Staphylococcus aureus</i> Strains Possessing the <i>cfr</i> Methyltransferase Gene or Ribosomal Mutations

Jeffrey B. Locke, John M. Finn, M.T. Hilgers et al. · Antimicrobial Agents and Chemotherapy · 2010 · 145 citations · Full text

Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

Jeffrey B. Locke, M.T. Hilgers, Karen Joy Shaw · Antimicrobial Agents and Chemotherapy · 2009 · 133 citations · Full text

Oxazolidinone Resistance, Antibiotic Adjuvant, Genetics +17

Anthracimycin, a Potent Anthrax Antibiotic from a Marine‐Derived Actinomycete

Kyoung Hwa Jang, Sang‐Jip Nam, Jeffrey B. Locke et al. · Angewandte Chemie International Edition · 2013 · 122 citations · Full text

Anthrax Infections, Marine-derived Actinomycete, Antimicrobial Chemotherapy +16